INTRODUCTION
Acute pancreatitis (AP) is an unpredictable disease with a wide spectrum of clinical outcome ranging from a mild and reversible condition to a severe and life-threatening disorder characterized by coagulopathy and respiratory failure (1-3). Management of patients with severe AP is largely restricted to supportive therapies due to limited understanding of the underlying pathophysiology. Convincing data have shown that neutrophil recruitment constitutes a rate-limiting step in tissue damage associated with AP (4-7). Studies have revealed that neutrophil-derived reactive oxygen species (ROS) and enzymes, such as elastase and matrix metalloproteinase-9 (MMP-9) can contribute to tissue damage in AP (8, 9) . A recent investigation showed that neutrophil extracellular traps (NETs) play a significant role in trypsin activation, neutrophil recruitment and tissue injury in AP (10) . Another study showed that NETs contributes to secretory obstruction in the inflamed pancreas (11) . Although NETs appear to be important in the pathophysiology of AP, the mechanisms of NETs formation in AP remain elusive. NETs are decorated with nuclear, cytoplasmatic and granular proteins, which exert important biologic functions (12) . Activated neutrophils also shed off microparticles (MPs), i.e. sphere-shaped intact vesicles released from cell membranes with a size less than 1 µm (13) and recent evidence has shown that MPs form complexes with NETs via histone-phosphatidylserine interactions (14) . These NET-MP aggregates are powerful inducers of thrombin generation via the intrinsic pathway of coagulation (14) . However, it is not known whether MPs associates with NETs and contribute to inflammation and tissue injury in AP.
Beside their well-known function in haemostasis and thrombosis, accumulating data suggest that platelets exert pro-inflammatory effects in different models of inflammation (15). For example, several studies have shown that platelets support neutrophil recruitment to sites of inflammation via secretion of CD40L, CCL5 and CXCL4 (16) (17) (18) (19) . Moreover, convincing data have shown that platelets promote NET formation in response to challenge with bacterial and viral components (20) (21) (22) although the role of platelet-mediated NETosis in sterile inflammation remains elusive. Platelets are the main source of inorganic polyphosphates in mammalian cells and can secrete short PolyP polymers (60-100 residues) with potent effects on coagulation (23) . Moreover, recent publications indicate that PolyPs can also exert 4 pro-inflammatory effects, such as enhancing NF-B signaling and vascular permeability as well as activating complement system (24) (25) (26) . A previous study showed that inositol hexakisphosphate kinase 1 (IP6K1) is a critical enzyme regulating polyphosphate homeostasis in platelets (27). In addition, platelet IP6K1 has been reported to regulate formation of platelet-neutrophil aggregates (PNA) in endotoxininduced lung inflammation, suggesting a pro-inflammatory role in systemic inflammation (28) . However, the potential role of IP6K1 in the pathophysiology of AP has never been studied.
Based on the above considerations, we hypothesized herein that platelet IP6K1 might not only be involved in NETs formation but also regulate subsequent organ inflammation and injury in AP.
RESULTS

Platelets regulate formation of NET-MP aggregates in AP
Scanning electron microscopy revealed that challenge with taurocholate triggered formation of extracellular fibrillar and web-like structures in the pancreas compatible with NETs ( Figure 1A and C).
Moreover, transmission immunoelectron microscopy showed that the neutrophil-derived granule protein elastase as well as histone 4 co-localized with the extracellular DNA in these extracellular fibrillar and web-like structures ( Figure 1B) , which were not observed in the normal pancreas. An antibody directed against GP1BA was used to deplete mice of platelets ( Supplementary Figure 1 ). We found that platelet depletion markedly decreased NETs formation in the inflamed pancreas ( Figure 1A and C). As expected, treatment with DNase I abolished taurocholate-induced NETs formation in the pancreas ( Figure 1A and C). In addition, challenge with taurocholate enhanced plasma levels of DNA-histone complexes by 3-fold ( Figure 1E ). Depletion of platelets reduced DNA-histone complexes in plasma by 86% in animals with AP ( Figure 1E ). Taurocholate increased pancreatic levels histone 3 and histone 4 by 3-fold ( Figure 1F ) and 4-fold ( Figure 1G ), respectively. Platelet depletion greatly attenuated histone 3 and histone 4 levels in the inflamed pancreas ( Figure 1F and G). Moreover, by applying scanning electron microscopy, we found that taurocholate-induced NETs in the pancreas contained numerous round structures compatible with MPs ( Figure 1C ). Indeed, transmission electron microscopy revealed that these particles expressed CD41 or Mac-1 ( Figure 1D ), indicating that these MPs were of platelet and neutrophil origin, respectively.
Administration of DNase I abolished NET formation and consequently the density of MP on NETs was
close to zero in the pancreas of animals with acute pancreatitis ( Figure 1A and C-D). Platelet depletion, which reduced NET formation, also decreased the density of MPs on the remaining NETs ( Figure 1C 
Platelet-neutrophil aggregates in AP
Leukocyte-platelet aggregate formation is a common feature in inflammatory conditions (29) (30) (31) and we hypothesized that such complex formation may influence neutrophil activation and NETs formation. It was found that taurocholate challenge markedly enhanced formation of PNA formation in the circulation of mice with AP (Figure 2A-B ). Moreover, immunoneutralization of P-selectin markedly reduced taurocholate-induced formation of PNA (Figure 2A-B ). Next, we examined if P-selectin-mediated contact between platelets and neutrophils is important for NETs formation. It was found that thrombin stimulation of co-incubated platelets and neutrophils increased formation of DNA-histone complexes ( Figure 2I ).
Interestingly, inhibition of P-selection abolished thrombin-induced formation of DNA-histone complexes in mixtures of platelets and neutrophils, suggesting that P-selectin-mediated contact between neutrophils and platelets is important for NET formation ( Figure 2I ). Indeed, immunoneutralization of P-selectin markedly decreased taurocholate-induced NETosis in the inflamed pancreas ( Figure 2F 
NET-MP complexes regulate trypsin activation in acinar cells
We next asked if MPs attached to NETs play a role in AP. As shown recently (14) , PMA stimulation of neutrophils triggers formation of NETs containing numerous MPs ( Figure 3A ). Co-incubation of neutrophils with calpain and caspase inhibitors resulted in formation of NETs with markedly less MPs ( Figure 3B ). It was found that NETs depleted of MPs had a significantly lower capacity to trigger amylase secretion from acinar cells in vitro ( Figure 3E ). Signal transducer and activator of transcription-3 (STAT-3) is an important signaling molecule in acinar cells (32) . It was found that NETs stimulation markedly Notably, co-incubation with caspase and calpain inhibitors decreased NET-induced STAT-3 phosphorylation by 44% ( Figure 3F -G). However, co-incubation of acinar cells with neutrophil-derived MPs alone had no effect on amylase secretion ( Figure 3E ) or STAT-3 phosphorylation ( Figure 3F -G).
Importantly, co-incubation of neutrophils with calpain and caspase inhibitors had no effect on the levels of PMA-induced DNA-histone complex levels or NETs content of histone 4 ( Figure 3C -D). We next examined gene expression of STAT-3-targets IL-6 and TGFB1 in acinar cells. We observed that NET challenge greatly enhanced acinar cell mRNA levels of IL-6 ( Figure 3H ) and TGFB1 ( Figure 3I ). Coincubation with DNase I or calpain and caspase inhibitors significantly reduced NET-provoked gene expression of IL-6 and TGFB1 in acinar cells ( Figure 3H -I). MPs alone had no effect on mRNA levels of IL-6 and TGFB1 in acinar cells ( Figure 3H -I).
IP6K1 regulates NET formation in AP
By use of electron microscopy, it was found that NETs formation in the pancreas was markedly reduced in IP6K1-deficient mice exposed to taurocholate ( Figure 4A -C). Taurocholate challenge increased DNAhistone complexes in plasma by more than 7-fold ( Figure 4D ). Plasma levels of DNA-histone complexes triggered by taurocholate was decreased by 81% in animals lacking IP6K1 ( Figure 4D ). We next quantified tissue levels of histones in the pancreas. Pancreatic levels of histone 3 and histone 4 were low in sham animals ( Figure 4E -F). Challenge with taurocholate enhanced pancreatic levels of histone 3 and histone 4 by 52-fold ( Figure 4E ) and 25-fold ( Figure 4F ), respectively. We found that taurocholateprovoked increases in histone 3 and histone 4 levels were reduced by more than 97% and 87%, respectively, in the inflamed pancreas of IP6K1 gene-deficient mice ( Figure 4E -F). Notably, there were no differences in the number of leukocyte subtypes and platelets between wild-type and IP6K1-deficienct animals (Supplementary Figure 5 ).
IP6K1-dependent inflammation and tissue damage in AP
Blood levels of amylase were assessed as an indicator of tissue damage in AP. Challenge with taurocholate enhanced amylase levels by nearly 21-fold ( Figure 5A ). Taurocholate-induced increase in amylase was decreased by 65% in IP6K1-deficient animals ( Figure 5A ). Tissue levels of MPO were used as an indicator of neutrophil infiltration. We found that infusion of taurocholate increased pancreatic MPO activity by 12-fold ( Figure 5B ). Taurocholate-provoked pancreatic levels of MPO was attenuated by 86% in mice lacking IP6K1 ( Figure 5B ). Moreover, taurocholate increased formation of CXCL1 was significantly decreased in IP6K1 gene-deficient animals ( Figure 5C ). Morphologic examination revealed normal microarchitecture in pancreas tissue from control animals ( Figure 5D ), whereas taurocholate challenge caused severe destruction of the pancreatic tissue structure characterized by extensive edema, acinar cell necrosis, haemorrhage in the interstitial tissue and massive infiltration of neutrophils ( Figure   5E and G-J). IP6K1 knock-out mice were protected from taurocholate-provoked destruction of the tissue architecture ( Figure 5F and G-J). For example, taurocholate-induced edema, acinar cell necrosis, haemorrhage and leukocyte accumulation were reduced by 64%, 61%, 63% and 62%, respectively, in Herein, we observed that MPO levels in the lung was attenuated by 66% ( Figure 5M ), plasma levels of MMP-9 by 80% ( Figure 5L ) and IL-6 by 90% ( Figure 5K ) in IP6K1 knock-out mice exposed to taurocholate.
The IP6K inhibitor TNP decreases NET formation, inflammation and tissue injury in AP
Data above suggest that IP6K1 is a potential therapeutic target in AP, and thus, we next wanted to study if TNP, a specific inhibitor of IP6Ks (33), could ameliorate taurocholate-induced inflammation and tissue damage. Again, challenge with taurocholate increased NET formation in the pancreas ( Figure 6A ).
Treatment with TNP markedly decreased NET formation in the inflamed pancreas ( Figure 6A -C). In addition, administration of TNP reduced DNA-histone complex levels in the plasma by 63% and histone 9 3 and 4 levels in the pancreas by 68% and 67%, respectively, in animals exposed to taurocholate ( Figure   6D -F). Notably, we found that administration of TNP attenuated amylase by 48%, pancreatic MPO activity by 75% and CXCL1 levels by 67% in mice with AP ( Figure 7A-C) . Moreover, animals treated with TNP were protected from taurocholate-induced tissue damage ( Figure 7I-L) . For example, TNP decreased edema by 53%, haemorrhage by 46% and acinar cell necrosis by 44% in the inflamed pancreas ( Figure 7M-O) .
Platelet-derived inorganic polyphosphates regulate NETs formation
IP6K1 is known to regulate platelet homeostasis of polyphosphate formation (27) and we therefore wanted to examine the role of polyphosphates in formation of NETs. First, we observed that IP6K1 disruption reduced the amount of polyphosphates in platelets (Supplementary Figure 4A-B ). Next, we coincubated wild-type or IP6k1-deficient platelets together with wild-type neutrophils. Stimulation of wildtype platelets and neutrophils with thrombin resulted in significantly increased formation of DNA-histone complexes (Supplementary Figure 4C) . In contrast, thrombin stimulation of IP6K1-deficient platelets coincubated with wild-type neutrophils led to a 59% reduction in DNA-histone complexes (Supplementary Figure 4C ). Interestingly, polyphosphate rescue dose-dependently restored formation of DNA-histone complexes in thrombin stimulated mixtures of IP6K1-deficient platelets and wild-type neutrophils (Supplementary Figure 4C ). By use of confocal microscopy, we observed that thrombin stimulation of wild-type platelets and neutrophils resulted in the expulsion of DNA co-localizing with MPO and citrullinated histone 3, indicating NET formation ( Figure 8B ). No expulsion of DNA was observed when IP6K1-deficient platelets and wild-type neutrophils were stimulated with thrombin ( Figure 8C ). Notably, NETs formation was restored when IP6K1-deficient platelets and wild-type neutrophils were rescued by addition of polyphosphate ( Figure 8D ). In separate experiments, wild type and IP6K1-deficient neutrophils were co-incubated with PMA and it was found that PMA-induced NET formation was independent of IP6K1 in neutrophils ( Supplementary Figure 6A-C) .
IP6K regulates NET formation and tissue injury in L-arginine-induced AP
In order to examine whether IP6K also regulates NET formation, tissue damage and neutrophil recruitment in an alternative experimental model, L-arginine was used to trigger AP. Challenge with Larginine increased NET formation in the pancreas (Supplementary Figure 7A-C) , plasma levels of DNAhistone complexes (Supplementary Figure 7D ) and pancreatic levels of citrullinated histone 3 formation (Supplementary Figure 7E ). Administration of TNP significantly decreased NET formation in animals exposed to L-arginine ( Supplementary Figure 7A 
DISCUSSION
Due to limited understanding of the underlying pathophysiology and lack of specific treatment, mortality rate of patients with severe AP and systemic complications is still as high as 25%. This study documents that platelets are potent regulators of NET-MP complex formation in the inflamed pancreas. These NET-MP complexes activate and stimulate amylase secretion from acinar cells. Moreover, our data show that platelet IP6K1 is a potential target to inhibit NETs formation and tissue damage in AP.
Convincing evidence in the literature suggest NETs play a significant role in the development of AP (10, 11) . Knowing that platelets facilitate neutrophil activation and recruitment (16, 22, 34) , we hypothesized that platelets might regulate NETs formation in AP. Indeed, we found that platelet depletion markedly reduced deposition of DNA co-localizing with the neutrophil-derived granule protein elastase and histone 4, suggesting that platelets regulates NET formation in the inflamed pancreas. Previous work has shown that platelets contribute to NET formation in response to challenge with bacterial and viral components (20) (21) (22) but this study suggest that platelet-mediated NETosis is also in involved in sterile inflammation. Moreover, it was found that taurocholate challenge increased DNA-histone complexes in plasma as well as histone 3 and histone 4 levels in the pancreas. Notably, platelet depletion greatly reduced DNA-histone complexes in plasma and histone levels in the pancreas in animals exposed to taurocholate, which further supports the notion that platelets regulate NETs generation in AP. Knowing that NET-derived histones can directly cause epithelial cell damage (35) and trypsinogen activation in acinar cells (10) , our findings indicate that decreased pancreatic levels of histone 3 and histone 4 might help to explain part of the beneficial effect of depleting animals of platelets in AP. A pioneering study in this field showed that TLR4 regulates platelet-mediated NETosis in enodotoxemia (20) . Considering that TLR4 has also been reported to play an important role in neutrophil recruitment and tissue damage in AP (36) it is possible that platelet TLR4 might be involved in NETs formation in the inflamed pancreas, which should be addressed in future studies. NETs are known to be loaded with numerous different nuclear, cytoplasmatic and granular proteins, which contribute to the biological effects of NETs (12, 37) .
We have recently demonstrated that MPs formed during neutrophil activation can bind to NETs and form NET-MP complexes, which are important for thrombin generation in sepsis (14) . Herein, we observed that taurocholate challenge increased the number of NET-MP aggregates in the pancreas and that depletion of platelets decreased NET-MP aggregates in the inflamed pancreas. Moreover, these NETassociated MPs were found to express Mac-1 or CD41, suggesting that both neutrophil-and plateletderived MPs formed complexes with NETs in the inflamed pancreas. We next asked whether these NET-MP aggregates might play an important role in acinar cell biology. By use of electron microscopy, we could confirm that co-incubation of caspase and calpain inhibitors abolished concomitant generation MPs resulting in formation of NETs without MPs. Notably, these MP-depleted NETs were significantly less effective in triggering amylase secretion, STAT-3 phosphorylation and gene expression of IL-6 and TGFB1 in acinar cells compared to NET-MP aggregates. In this context, it should be mentioned that coincubation with caspase and calpain inhibitors did not impact the amount of NET formation or the histone content of NETs depleted of MPs. Thus, these finding suggest that NETs constitute a functional assembly scaffold for MPs in AP.
Several studies have shown that circulating platelet-leukocyte complexes is a frequent phenomenon in a wide range of inflammatory conditions, including reperfusion injury (29) , abdominal sepsis (30), pulmonary infections (31) , and acute myocardial disease (38) . Although, the potential function of such aggregates in inflammation has attracted a lot interest recently the actual role of platelet-leukocyte complexes has not been identified. It was therefore of great interest to examine the role of aggregate formation in platelet-leukocyte interactions in the present study. We found that the percentage of plateletneutrophil complexes increased by 7-fold in mice with pancreatitis, which is in line with previous observations in AP (34) . In addition, it was observed that inhibition of P-selectin not only abolished formation of PNA but also significantly decreased NETs formation in the inflamed pancreas. Moreover, we observed that thrombin stimulation of mixtures of platelets and neutrophil resulted in clear-cut generation of NETs and that immunoneutralization of P-selectin significantly reduced this NETs formation. These findings indicate that physical contact between platelets and neutrophils are important for platelet-mediated NETosis. In this context, it is interesting to note that a recent study reported that 13 IP6K1 plays a key role in platelet-mediated neutrophil activation and recruitment in the lung in systematic inflammation via formation of neutrophil-platelet aggregates (28) . Thus, we next asked whether IP6K1 could play a role in platelet-dependent NETs generation in AP. We found that taurocholate-induced NET-MP complex, histone 3 and histone 4 formation in the pancreas as well as generation of DNA-histone complexes in plasma were markedly reduced in mice lacking IP6K1, showing for the first time in the literature that IP6K1 is a key regulator of NETs formation. It is well accepted that neutrophil infiltration is a rate-limiting step in tissue damage the inflamed pancreas (4-6). Herein, it was observed that the taurocholate enhanced MPO levels and neutrophil extravasation in the pancreas were attenuated by 86% and 62%, respectively, in IP6K1 gene-deficient mice. CXC chemokines secreted from resident tissue cells co-ordinate tissue navigation of neutrophils (39) . We found that taurocholate caused a clear-cut increase in CXCL1 formation in the pancreas and that generation of CXCL1 was abolished in pancreatitis animals lacking IP6K1, indicating that decreased expression of CXCL1 could help explain diminished neutrophil recruitment and tissue damage in the pancreas of IP6K1-deficient mice exposed to taurocholate. Severe AP is characterized by systemic complications including pulmonary neutrophilia (6, 36) . Herein, we observed that the taurocholate-induced increase in MPO activity in the lung was greatly decreased in IP6K1 gene-deficient mice. Moreover, IP6K1-deficient animals were protected from increases in systemic levels of IL-6 and MMP-9. In addition, these findings suggest that IP6K1 not only regulates local inflammation but also systemic inflammation in animals with AP. Together, our data show that disruption of IP6K1 not only markedly decreased NETs formation in the inflamed pancreas but also reduced inflammation and pancreatic damage in animals with AP, suggesting that IP6K1 is a key regulator of the development of AP. These findings indicate that IP6K1 could be a useful therapeutic target in AP. This notion is supported by our findings showing that the IP6K specific inhibitor TNP (28, 33) , greatly attenuated taurocholate-induced NETs formation, local inflammation and tissue damage in the pancreas as well as systemic inflammation and pulmonary neutrophilia in animals with AP. In addition, we found that TNP also reduced NET formation , inflammation and tissue injury in an alternative model of AP, i.e., L-arginine-induced pancreatitis.
Having established an important function of IP6K1 in NETs formation and AP, we next wanted to define the role of platelet IP6K1 in mediating NETs formation. We found that thrombin stimulation of mixtures of wild-type platelets and neutrophils triggered clear-cut NET formation. In contrast, thrombin activation of mixtures of IP6K1-deficent platelets and wild-type neutrophils resulted in markedly decreased NETs generation. Moreover, PMA stimulation of IP6K1-deficent neutrophils exhibited intact NET formation. Taken together, these findings suggest that platelet, and not neutrophil, IP6K1 is responsible for NETs formation. In this context, it is interesting to note that a recent study showed that IP6K1 is critical in regulating platelet hemostasis of PolyPs (27). Indeed, we observed herein that IP6K1deficient mice have reduced levels of platelet PolyPs. Accumulating data suggest that PolyPs can exert several pro-inflammatory effects, such as activation of the kallikrein-kinin (26) and complement systems (40) . Thus, we hypothesized in the present study that platelet PolyP could be involved in NETs formation.
In fact, we found that reduced NET formation in response to thrombin stimulation of IP6K1-deficent platelets and wild-type neutrophils is likely due to decreased production of PolyPs in IP6K1-deficent platelets because this defect was rescued by addition of exogenous PolyP. Thus, these results indicate that platelet IP6K1 is a novel regulator of NETosis via secretion of PolyP, which could have significant impact not only on AP but also other conditions, such as sepsis, infection, and autoimmune diseases, in which NETs play a pathophysiological role. As stated above, PolyPs have pleiotropic effects on inflammation and our present findings do not exclude other mechanisms operating in parallel to plateletmediated NETs formation. For example, it has recently been shown that PolyPs stimulate generation of bradykinin via the intrinsic pathway of coagulation (26) . Bradykinin is a potent activator of neutrophils and whether such mechanisms are at work in AP remains to be studied. In this context, it should be mentioned that our findings do not exclude that lack of IP6K1 in vivo could also impact coagulation or other systems independent NETs formation. Nonetheless, considering our present findings together with the fact that PolyPs are a potent stimulus of the coagulation system (26) it could be suggested that blocking IP6K1 could be a useful strategy to concomitantly antagonize pathological inflammation and coagulation constituting key features of patients with severe AP.
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Taken together, this study shows for the first time that platelets regulate formation of NETs in the inflamed pancreas. Moreover, we could document that NETs form aggregates with MPs in the inflamed pancreas and that these NET-MP complexes are potent stimuli for amylase secretion and STAT-3 activation in acinar cells. Our data also demonstrate that IP6K1 is a key regulator of NETs formation, inflammation and tissue damage in AP possibly via PolyP secretion from platelets. Thus, these findings identify a new function of IP6K1 in pancreatitis and suggest that targeting IP6K1 could be beneficial to attenuate local and systemic inflammation in severe AP. electron microscopy and one third was snap-frozen in liquid nitrogen for biochemical quantification of pancreatic myeloperoxidase (MPO), CXCL1, histone 3 and histone 4 levels. One third was fixed in formalin for histological analysis. Lung tissue was harvested for pulmonary MPO measurement.
L-arginine-induced pancreatitis
In separate experiments, AP was induced by administration of L-arginine (4 g/kg/dose) i.p. twice at an interval of 1h as described in detail previously (44) . Vehicle or TNP (N2-(m-Trifluorobenzyl), N6-(pnitrobenzyl) purine (20 mg/kg, Tocris bioscience, Bristol, UK)) were given i.p. before the first dose of Larginine. Saline-treated animals served as negative controls. All animals were sacrificed 72 h after induction of pancreatitis.
NETs Generation in Vitro
Isolated bone marrow neutrophils (4 x10 6 cells/ml) were challenged with 50 nM PMA (Sigma-Aldrich, Stockholm, Sweden) for 3 h at 37°C in RPMI 1640. In indicated experiments, cells were co-incubated with caspase (50 µM, Z-VAD-FMK, R&D Systems) and calpain (25 µM, PD150606, Sigma-Aldrich) inhibitors, which has been shown to generate NETs without MPs (14) . Supernatants were discharged and fresh media was added to isolate NETs. Residual neutrophils and NETs were removed through extensive pipetting. The mixture was centrifuged at 200 g (5 min) to remove cellular components and NETcontaining supernatants were collected. NET-containing supernatants were further centrifuged at 19000 g (15 min) to collect NETs. For MP preparation, supernatants were subjected to high centrifugation (21 000 g for 1h at 4°C). Supernatants were removed and the pellets finally resuspended in phosphate buffer saline (PBS). Isolated acinar cells were co-incubated with NETs, amylase secretion and STAT-3 phosphorylation and mRNA levels of IL-6 and TGFB1 were determined as described in Supplementary methods.
Statistics
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Graphpad Prism 7 was used for data analysis. Data are presented in box plot (25-75 percentiles) where horizontal line indicates median of the group; whiskers extend from the minimum to the maximum values. Statistical comparisons were performed using non-parametrical tests (Mann-Whitney or ANOVA on ranks followed by Dunnett's multiple comparisons). P < .05 was considered significant and n represents the number of animals or experiments.
Study approval
Animal experiments were performed according to the recommendations of the Guide for the Care and Use of Laboratory Animals, published by the US national institutes of health and approved by the ethical committee at Lund University, Sweden (Permit number: 18726/2017). The ARRIVE guidelines (41) and an editorial on the application of ARRIVE guidelines to pharmacological studies (42) were consulted for all in vivo studies involving animals.
